Shares of 10x Genomics, Inc. (NASDAQ:TXG – Get Free Report) have received a consensus rating of “Hold” from the seventeen analysts that are currently covering the company, Ratings reports. One ...

Single-cell transcriptomics has revolutionized the study of cellular diversity and function by enabling gene expression ...

Genomics (NASDAQ:TXG – Get Free Report)‘s stock had its “sell (e+)” rating restated by equities researchers at Weiss Ratings in a note issued to investors on Friday,Weiss Ratings reports. A number of ...

Xiaomi Redmi 10X 5G is officially announced in May 2020. The smartphone is fueled by a Non-removable Li-Po 4520 mAh battery + Fast charging 22.5W. The phone runs on the Android 10.0 + MIUI 11 ...

The chart above depicts the trend in analyst earnings per share (EPS) forecasts for 10X Genomics Inc for the upcoming quarter. Analysts have reduced this quarter's expectations by -81.2% for EPS from ...

The certified compatibility is between 10x Genomics’ latest Chromium Universal GEM-X 3’ and GEM-X 5’ single-cell chemistries — which enhance sensitivity while reducing cost per cell — and Oxford ...

Following the manufacturer’s protocol, scRNA-Seq libraries were prepared using the 10× Genomics Chromium Single-Cell 3’ kit (V3) and subsequently sequenced using an Illumina NovaSeq 6000 platform at ...

Building on a record year of Chromium product releases in 2024, 10x Genomics announced plans to enable high-performance, mega-scale single cell analysis with improved efficiency and ease of use.

Building on a record year of Chromium product releases in 2024, 10x Genomics announced plans to enable high-performance, mega-scale single cell analysis with improved efficiency and ease of use.